title: Progressive multifocal leukoencephalopathy, efalizumab, and immunosuppression: a cautionary tale for dermatologists.
authors.affiliation: Murdough Family Center for Psoriasis, Department of Dermatology, University Hospitals Case Medical Center, 11100 Euclid Ave, Cleveland, OH 44106, USA.
authors.forename: Benjamin D
authors.initials: BD
authors.lastname: Korman
authors.forename: Kenneth L
authors.initials: KL
authors.lastname: Tyler
authors.forename: Neil J
authors.initials: NJ
authors.lastname: Korman
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000175:diagnosis; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D018845:CD11 Antigens; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D007577:JC Virus; D007968:Leukoencephalopathy, Progressive Multifocal / Q000139:chemically induced* / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D012307:Risk Factors; D012871:Skin Diseases / Q000188:drug therapy
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D018845:CD11 Antigens; D007166:Immunosuppressive Agents; C472181:efalizumab